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Abstract 
The present study has been designed to investigate the antioxidant and antitumor activities of 
ethyl acetate (EA) extract of stem bark of Polyalthia simiarum (Annonaceae). Antioxidant potential of 
the EA extract was evaluated in vitro by DPPH (1,1-diphenyl-2-picrylhydrazyl) scavenging assay 
method. The EA extract showed free radical scavenging activity with IC50 value of 24.08 ± 0.30 µg/mL. 
The antitumor activity of the extract was determined against Ehrlich ascites carcinoma (EAC) in mice at 
25 mg/kg and 50 mg/kg body weight intraperitoneally. Significant (p<0.001) increase of survival time by 
25 ± 0.57 and 27 ± 0.40 days by the EA extract treated tumor bearing mice was confirmed with respect 
to the control group (22 ± 0.12 days). Hematological studies revealed that the hemoglobin (Hb) content 
was decreased in EAC treated mice whereas restoration to close to normal levels was observed in 
extract treated animals. There was a significant (p<0.001) decrease in RBC and increase in WBC counts 
in extract treated animals when compared to EAC affected animals. Therefore, the EA extract of P. 
simiarum was capable to exhibit moderate antioxidant and antitumor activities. This is the first report of 
antioxidant and antitumor potential of P. simiarum. 
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Polyalthia simiarum (Buch.-Ham. ex Hook. F. & Thomson) Hook. F. & 
Thomson'un Antioksidan ve Antitümör Aktivitesi 
Bu çalismada Polyalthia simiarum (Annonaceae) ’un gövde kabuğunun etil asetath ekstresi (EA) 
antioksidan ve antitümör aktiviteleri bakımından incelenmiştir. EA ekstresinin antioksidan potensiyali in 
vitro olarak DPPH (1,1-difenil-2-pikrilhidrazil) radikali süpürücü etki He dlculmustiir. EA ekstresi 24.08 
± 0.30 µg/mL IC50 değeri He serbest radikal süpürücü aktivite göstermiştir. Ekstrenin antitümör 
aktivitesi intraperitoneal olarak 25 mg/kg ve 50 mg/kg vücut agirhginda farede Ehrlich ascites 
karsinoma (EAC) ’ya karsi belirlenmiştir. EA ekstresi uygulanan tümor tasiyan farelerde hayatta kalma 
süresi kontrol grubuna göre (22 ± 0.12 gün) 25 ± 0.57 ve 27 ± 0.40 gün ile belirgin (p<0.001) bir artis 
göstermiştir. Hematolojik çalismalar hemoglobin (Hb) içeriğinin EAC farelerde azaldiginı, bununla 
birlikte ekstre verilen hayvanlarda normal düzeylere yakın hale geldiğini göstermiştir. EAC tasiyan 
hayvanlarla karsilaştırıldiginda, ekstre uygulanan hayvanlarda WBC değerinde artma ve RBC 
değerinde belirgin (p<0.001) bir azalma vardır. Bu sonuçlara bağlı olarak, P. simiarum’un EA ekstresi 
orta düzeyde antioksidan ve antitümör aktiviteye sahiptir. Bu çalisma P. simiarum ’un antioksidan ve 
antitümör etkilerinin incelendiği ilk çalismadır. 
Anahtar kelimeler: Antitümör, Ehrlich ascites karsinoma, Serbest radikal, Polyalthia simiarum 
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INTRODUCTION 
The morbidity and mortality of cancer, the second leading cause of death worldwide next to 
cardiovascular diseases, is characterized by uncontrolled cellular growth, local tissue invasion, 
and distant metastases (1). Free radicals, one of the major causes for the conversion of normal 
cell to cancerous cells, are generated as a consequence of a number of endogenous metabolic 
processes involving redox enzymes and bioenergetic electron transfer and exposure to a plethora 
of exogeneous chemicals (2). In normal metabolic condition, oxidant and antioxidant levels are 
maintained in balance within humans for sustaining optimal physiological conditions (3). 
However, overproduction of free radical and reactive oxygen species (ROS) would assault on 
important biological molecules such as DNA, protein or lipid leading to many degenerative 
processes, such as cancer, Alzheimer’s disease, arthritis and ischemic reperfusion (4). More and 
more evidences suggest that this potentially cancer-inducing oxidative damage might be 
prevented or limited by antioxidants which may mediate their effect by directly reacting with 
ROS, quenching them or chelating the catalytic metal ions (5). It has been shown that 
antioxidant rich diet can reduce oxidative damage to DNA, thus preventing a critical step in the 
onset of carcinogenesis and the impact of antioxidant on mutagenesis and carcinogenesis has 
been well established (6,7). Moreover, the increase of cancer incidence and lack of appropriate 
anticancer drugs have forced scientists to pharmacological and chemical investigation of 
anticancer agents from medicinal plant (8). The worldwide upsurge in the use of herbal 
preparation and medicinal plant along with their isolated active compounds has provided one of 
the most important sources for pharmaceutical industry for lead compounds. Furthermore, over 
a 100 new products are in clinical development, particularly as anti-cancer and anti-infective 
agents (9). Although, the mechanism of interaction between phytochemicals and cancer cells 
has been studied extensively and augmented the interest of pharmacological evaluation of 
various plants used in Bangladeshi traditional systems of medicine (10). 
The genus Polyalthia (Annonaceae) comprises about 70 species, out of which only eight are 
indigenous to the Indian subcontinent (11). P. simiarum (Buch.-Ham. ex Hook. f. & Thomson) 
Hook. f. & Thomson, locally known as Arjan, is a very tall tree. In the traditional system of 
medicine, the plants of this genus are used as a bitter tonic, abortifacient, febrifuge, cure for 
scorption strings, hypertension and as respiratory stimulant (12). Biological evaluations of 
Polyalthia species have shown them to exhibit cytotoxic, antimicrobial (13), anticancer (14), 
antimalarial (15) and HIV-inhibitory (16) activities. The plant P. simiarum is known to exhibit 
antimicrobial and cytotoxic (17) activities. Previous phytochemical investigations with 
Polyalthia species revealed to contain alkaloids (azafluorene, polylongine and aporphine), 
steroid, diterpenoids and pentacyclic triterpenes (18). Very recently the petroleum ether extract 
of stem bark of P. simiarum led to the isolation of a bisnor-type clerodane diterpenoid, 2-oxo-
14,15-bisnor-3,11E-kolavadien-13-one and three clerodane derivatives, kolavenic acid, 16β-
hydroxycleroda-3,13(14)Z-dien-15,16-olide and 16-oxocleroda-3,13(14)E-dien-15-oic acid (19). 
As not enough phytochemical and biological studies have been carried out with P. simiarum, the 
present study was conducted to evaluate the antioxidant potential by DPPH and antitumor 
activity of ethyl acetate extract of the stem bark of P. simiarum against Ehrlich ascites 
carcinoma (EAC) in mice. 
EXPERIMENTAL 
Plant material 
The stem bark of Polyalthia simiarum (Buch.-Ham. ex Hook. f. & Thomson) Hook. f. & 
Thomson was collected from Mirpur, Dhaka in the month of June 2008 and identified by Mr. 
Sarder Nasir Uddin, Scientific Officer, Bangladesh National Herbarium, Dhaka, where a 
voucher specimen (DACB-34201) representing this collection has been deposited. 
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Chemicals 
Sodium chloride, propylene glycol, trypan blue, methylene blue, methyl violet and sodium 
sulfate, were purchased from Merck Limited, Mumbai, India. All other chemicals and reagents 
used were of highest analytical grade. 
Preparation of extract 
The air dried and powdered plant material (700 g) was extracted in a Soxhlet apparatus with 
ethyl acetate (60-80°C). The extract was filtered through a fresh cotton plug followed by 
Whatman number 1 filter paper. The filtrate was then concentrated with a Buchii rotavapor at 
low temperature and pressure to afford ethyl acetate extract (EA, 7.52 g approx.). 
Preliminary phytochemical investigation 
The extract was subjected to qualitative chemical investigation for the identification of 
different phytoconstituents like sterols, glycosides, saponins, carbohydrates, alkaloids, 
flavonoids, tannins, proteins and terpenoids (20). 
Animals 
Swiss albino mice (25-30 g) of both sexes were used for assessing the biological activity. 
The animals were maintained under standard laboratory conditions and had free access to food 
and water ad libitum. The animals were allowed to acclimatize to the environment for 7 days 
prior to experimental session. The animals were divided into different groups, each consisting of 
five animals which were fasted overnight prior to the experiments. The experiments with the 
animals were performed in accordance with guidelines of the Institutional Animal Ethics 
Committee, Department of Applied Chemistry & Chemical Engineering, University of 
Rajshahi, Rajshahi, Bangladesh. 
Acute toxicity 
The acute oral toxicity of the plant extract in Swiss albino mice was 
established protocol (21). 
In vitro Antioxidant Activity 
Free radical scavenging activity by 1,1-diphenyl-2-picryl-hydrazyl (DPPH) assay 
The free radical scavenging activity of EA extract, based on the scavenging of the stable 
1,1-diphenyl-2-picrylhydrazyl (DPPH) free radical, was determined by the method described by 
Braca et al. (22). The percentage inhibition was calculated from [(A0–A1)/A0] x 100, where A0 
is the absorbance of the control, and A1 is the absorbance of the extract/ standard. IC50 value was 
calculated by plotting a graph of concentration (µg/mL) versus % inhibition. 
In vivo Antitumor Activity 
Transplantation of tumor 
Ehrlich ascites carcinoma (EAC) cells were obtained from Indian Institute of Chemical 
Biology (IICB), Kolkata, India. The EAC cells were maintained in vivo in Swiss albino mice by 
intraperitoneal transplantation of 2×106 cells per mouse after every 10 days. Ascitic fluid was 
drawn out from EAC tumor bearing mouse at the log phase (days 7–8 of cell implantation) of 
the tumor cells. Each animal received 0.1 mL of tumor cell suspension containing 2×106 tumor 
cells intraperitoneally. 
Treatment schedule 
60 Swiss albino mice were divided into five groups (n =12) and given food and water ad 
libitum. All the animals in each group except Group-I received EAC cells (2×106 cells/mouse, 
i.p.). This was taken as day ‘0’. Group-I served as normal saline control (5 mL/kg b.w., i.p.) and 
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Group-II served as EAC-treated control. After 24 h of EAC transplantation, Group-III and 
Group-IV received EA extract of P. simiarum stem bark at 50- and 25 mg/kg b.w., i.p. for nine 
consecutive days, respectively. Group-V received reference drug Bleomycin (0.3 mg/kg b.w., 
i.p.) for nine consecutive days (23). After 24 hours of last dose and 18 h of fasting, 6 animals 
from each group were sacrificed by cervical dislocation to measure antitumor and hematological 
parameters and the rest were kept with food and water ad libitum to check percentage increase 
in life span of the tumor bearing host. The antitumor activity of the extract of P. simiarum was 
measured in EAC-treated animals with respect to the following parameters. 
Determination of tumor volume and weight 
The mice were dissected and the ascitic fluid was collected from the peritoneal cavity. The 
volume was measured by taking it in a graduated centrifuge tube and weighed immediately. 
Tumor cell count 
The ascitic fluid was taken in a WBC pipette and diluted 100 times with normal saline and 
then a drop of the diluted cell suspension was placed on the Neubauer’s counting chamber and 
the number of cells in the 64 small squares was counted. 
Viable/nonviable tumor cell count 
The viability and non viability of the cells were checked by trypan blue assay with the help 
of microscope. The cells were stained with trypan blue (0.4% in normal saline) dye. The cells 
that did not take up the dye were viable and those that took the dye were nonviable. These 
viable and nonviable cells were counted using the following equation: 
Cell count = (Number of cells × dilution factor)/ (Area × thickness of liquid film) 
Determination of median survival time and percentage increase in life span 
The mortality was monitored by recording percentage increase in life span (%ILS) and 
median survival time (MST) (24). 
Body weight 
Body weights of the experimental mice were recorded both in the treated and control groups 
at the beginning of the experiment (day 0) and sequentially on every 9th day during the treatment 
period. 
Hematological parameters 
Collected blood was used for the estimation of hemoglobin (Hb) content, red blood cell 
(RBC) and white blood cell count (25). 
Statistical analysis 
Antitumor data are expressed as mean ± S.E.M. (n = 6 mice per groups). Statistical 
significance (p) calculated by Student’s t test. P<0.001 and <0.05 were considered to be 
statistically significant. 
RESULTS AND DISCUSSION 
The phytoconstituents present in the EA extract of P. simiarum were identified by various 
chemical tests which showed the presence of alkaloids, terpenoids, phenolic and flavonoid 
compounds and steroids (Table 1). 
The acute toxicity study was conducted to establish the therapeutic index, i.e., the ratio 
between the pharmacologically effective dose and the lethal dose on the same strain and species. 
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The extract of P. simiarum was safe up to a dose of 1000 mg/kg b.w. (p.o.) body weight. 
Behavior of the animals was closely observed for the first 3h then at an interval of every 4h 
during the next 48h. The extract did not cause mortality in mice during 48h of observation but 
little behavioral changes, locomotors ataxia, diarrhea and weight loss were observed. Food and 
water intake had no significant difference among the group studied. 
Table 1. Result of chemical group tests of the EA extract of Polyalthia simiarum. 
Extract Triterpene Diterpene Flavonoid Phenol 
Polyalthia 
simiarum (EA) + +++ +++ ++ 
Sterol Alkaloid 
+++ ++ 
EA: Ethyl acetate extract; (+): Present; (-): Absent; (+ + +): Reaction intensity is high; (+ +): Reaction 
intensity is medium; (+): Reaction intensity is normal. 
The percentage (%) scavenging of DPPH free radical was found to be concentration 
dependent, i.e. concentration of the extract between 15.62-500 µg/ml greatly increasing the 
inhibitory activity (Figure 1). The IC50 value of the EA extract was 24.08± 0.30µg/mL, while 
ascorbic acid showed the value of 12.30 ± 0.11 µg/mL. 
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Figure 1. Free radical scavenging activity of different concentrations of EA 
extract of P. simiarum by DPPH radicals (PA: Polyalthia, AA: Ascorbic acid). 
Antitumor activity of extract against EAC tumor bearing mice was assessed by the 
parameters such as tumor volume, tumor weight, cell count (viable and non viable), mean 
survival time and % increase of life span. The results are shown in Table 2. The tumor volume, 
tumor weight and viable cell count were found to be significantly (p<0.001) increased and non-
viable cell count was significantly (p<0.001) low in EAC-treated control animals when 
compared with normal control animals. Administration of EA extract at dose of 50- and 25 
mg/kg b.w. significantly (p<0.05) decreased the tumor volume, tumor weight and viable cell 
count. Furthermore, the median survival time was increased to 27 ± 0.40 and 25 ± 0.57 (% ILS 
= 22.12 and 13.63) on administration of crude extract at 50- and 25 mg/kg b.w., respectively. 
All these results clearly indicate that the EA extract had capacity to inhibit the growth of solid 
tumor induced by EAC cell line in experimental animals. 
Hematological parameters (Table 3) of tumor bearing mice on 14 day were found to be 
significantly altered compared to the normal group. The total WBC count was found to be 
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increased with a reduction of Hb content of RBC. The total number of RBC showed a modest 
change. At the same time the EA extract at 50- and 25 mg/kg b.w. restored all the altered 
hematological parameters to almost close to normal. 
Table 2. Effects of the EA extract of Polyalthia simiarum on tumor volume, tumor weight, 
mean survival time (MST), percentage increase life span (% ILS), viable and non-





E A extract 
(25mg/Kg b.w.) 
Bleomycin 
Tumor volume (mL) 3.2 ± 0.21 0.79 ± 0.34 1.70 ± 0.028** 0.52 ± 0.21 
Tumor weight (g) 3.70 ± 0.24 1.22 ± 0.21 2.31 ± 0.026** 0.51 ± 0.11 
MST (days) 22 ± 0.12 27 ± 0.40 25 ± 0.57 44.6 ± 0.12 
% ILS 00.0 22.12 13.63 96.81 
Viable cell (× 107 cell/mL) 8.1 ± 0.22 0.23 ± 0.05 0.56 ± 0.024** 0.5 ± 0.05 
Non-viable cell (× 107 
cell/mL) 
0.5 ± 0.24 0.76 ± 0.54 1.13 ± 0.049** 3.3 ± 0.05 
Total cell (× 107 cell/mL) 8.6 ± 0.15 0.99 ± 0.21 1.69 ± 0.026** 3.8 ± 0.05 
Viable % 94.18 23.23 33.13 13.15 
Non-viable % 5.82 76.76 66.86 86.85 
Each p o int represent the me an ± SEM. (n=6 mice per group), *p<0. 05 statistica lly si gni fica nt wh e n 
compared with EAC control group. 
To determine the efficacy of natural antioxidants either as pure compounds or as plant 
extract, a great number of in vitro methods have been developed in which antioxidant 
compounds act by several mechanisms. DPPH is a stable free radical that accepts an electron or 
hydrogen radical to become a stable diamagnetic molecule (26) and is usually used as a 
substrate to evaluate the antioxidant activity of a compound (27). Based on the data obtained 
from this study, DPPH radical scavenging activity of EA extract (IC50 24.08 ± 0.30 µg/mL) was 
lower than the standard (IC50 12.30 ± 0.11 µg/mL). It was revealed that the EA extract 
demonstrated the proton donating ability and could serve as free radical inhibitor or scavenger. 
In fact, the radical scavenging capability of phenolic compounds are due to their hydrogen 
donating ability/number of hydroxyl groups present, which in turn, is closely related both to the 
chemical structure and spatial conformation, that can modify the reactivity of the molecules 
(28). 
Table 3. Effects of the EA extract of Polyalthia simiarum on hematological parameter in EAC 
bearing mice. 
Treatment RBC 
(cell x 103/mm3) 
WBC 
(cell x 103/mm3) 
Hemoglobin 
(g %) 
Normal control 5.39 ± 0.12 3.92 ± 0.32 13.90 ± 3.1 
EAC control 3.91 ± 0.80 5.84 ± 0.52 4.95 ± 1.80 
EA extract (50mg/kg) 4.83 ± 0.66 4.89 ± 0.32 7.93 ± 1.62 
EA extract (25mg/kg) 3.02±0.03** 3.03±0.28** 4.25±0.144** 
Bleomycin (0.3 mg/kg) 5.18 ± 0.12 3.15 ± 0.83 12.89 ± 2.93 
Each point represent the mean ± SEM. (n=6 mice per group), *p<0.001 statistically significant when 
compared with control group, **p<0.005 statistically significant when compared with EAC control group. 
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In EAC-treated tumor bearing mice, a regular rapid increase in ascetic tumor volume was 
observed. Ascetic fluid is the direct nutritional source for tumor cells and a rapid increase in 
ascetic fluid with tumor growth would be a way to meet the nutritional requirement of tumor 
cells (29). Treatment with EA extract of P. simiarum reduced the intraperitoneal tumor burden, 
thereby reducing the tumor volume, tumor weight, viable tumor cell count and increased the life 
span of the tumor bearing mice. The steadfast criteria for judging the potency of any anticancer 
drug are prolongation of life span of animals (30). It can therefore be inferred that the increase 
in life span of EA extract treated EAC bearing mice may be due to the decrease in the 
nutritional fluid volume and delay the cell division (31). 
Reduction in viable cell count and increased non viable cell count towards normal in tumor 
host suggest antitumor effect against EAC cell in mice. These demonstrated that the EA extract 
have direct relationship with tumor cells as these tumor cells are absorbed the anticancer drug 
by direct absorption in peritoneal cavity and this anticancer agent promote lysis of the cells by 
direct cytotoxic mechanism (32). Anemia and myelosuppression have been frequently observed 
in ascites carcinoma (33). Anemia is encountered in ascites carcinoma mainly due to iron 
deficiency, either by haemolytic or myelopathic conditions which finally lead to reduced RBC 
number (34). Treatment with EA extract brought back the hemoglobin level, RBC and WBC 
count more or less to normal levels, thus supporting its haematopoietic protective activity 
without inducing myelotoxicity, the most common side effects of cancer chemotherapy. 
Preliminary phytochemical studies indicated the presence of alkaloid, steroid, phenolic and 
flavonoid compounds in EA extract of P. simiarum. Literature survey shows that most of the 
polar compound i.e., alkaloids, flavonoids, phenolics etc are biologically active. Less polar 
compounds like simple alkaloids, flavonoids, terpenes and their oxygenated derivatives as well 
as more functional group containing compounds would be successfully extracted with ethyl 
acetate. Rana et al. (35) agreed with the present study. A number of scientific reports indicated 
that certain terpenoid, steroid and phenolic compounds and flavonoids have chemo preventive 
role in cancer through their effects on signal transduction in cell proliferation and angiogenesis 
(36). Phytosterols are able to be incorporated into the cell membrane, alter membrane fluidity 
and the activity of membrane bound enzymes. They alter signal transduction pathways leading 
to tumor growth and stimulate apoptosis in tumor cell lines. They have also shown to enhance in 
vitro human peripheral blood lymphocyte and T-cell proliferation in vitro, which suggests a 
possible stimulation of the immune system (37). Furthermore, flavonoids such as quercetin, 
kaemferol and their glycosides have been shown to possess antimutagenic and antimalignant 
effects (38). The antitumor activities of EA extract of P. simiarum are probably due to one or 
more of alkaloids, phenolic compounds, flavonoids as well as terpenoids present in the extract. 
In present study, it was observed that the EA extract of P. simiarum exhibited antioxidant 
activity as well as significantly reduced tumor growth, viability of tumor cells, normalized the 
hematological profiles and increased life span as compared with those of EAC treated control 
mice. Further chemical studies are underway to isolate the bioactive compounds responsible for 
these bioactivities. 
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